Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL7144777

Cc1[nH]c2ccc(NC(=S)N3CCN(c4ccc(Cl)cc4Cl)CC3)cc2c1CCN(C)Cc1ccc2sc(N)nc2c1.O=S(=O)(O)C(F)(F)F

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.36
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 3/20 0.36
HTT P42858 2/20 0.36
EPHB2 P29323 1/20 0.35
PHGDH O43175 4/20 0.35
GAA P10253 2/20 0.34
RAD52 P43351 2/20 0.34
PKM P14618 1/20 0.34
BLM P54132 1/20 0.34
MAPK1 P28482 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
LMNA P02545 1/20 0.33
ATM Q13315 1/20 0.32
HTR1F P30939 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL8551955 0.91 KDM4E (0.37) MAPTALDH1A1KDM4EHTTPHGDH
SCHEMBL8552648 0.85 KDM4E (0.38) MAPTALDH1A1KDM4EHTTPHGDH
Trifluoromethanesulfonic Acid SCHEMBL8189875 0.80 HTR1F (0.56) MAPTALDH1A1KDM4EHTTEPHB2
Trifluoromethanesulfonic Acid SCHEMBL8194433 0.79 HSP90AA1 (0.40) MAPTKMT2A
Trifluoromethanesulfonic Acid SCHEMBL8545942 0.69 MGLL (0.36) MAPT
Trifluoromethanesulfonic Acid SCHEMBL7137485 0.69 POLB (0.38)
SCHEMBL7140235 0.68 ALDH1A1 (0.41) MAPTALDH1A1KDM4EEPHB2GAA
Trifluoromethanesulfonic Acid SCHEMBL8551417 0.68 GPR183 (0.35) MAPTALDH1A1KDM4E
SCHEMBL7145107 0.66 MAPT (0.43) MAPTALDH1A1KDM4EEPHB2GAA
SCHEMBL7141711 0.65 SMN1; SMN2 (0.45) MAPTALDH1A1KDM4EHTTPHGDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0768301-B1 N-(2-substituted-3-(2-aminoethyl)-1H-indol-5-yl)-amides as new 5-HT1F agonists LILLY CO ELI (US) 2003-04-02 EP disclosed
US-6126932-A INSOLUBLE POLYMER BEARING PENDANT SIDE CHAINS, SAID SIDE CHAINS EACH TERMINATING WITH THE 1-(3-(1-PYRROLIDINYL)-PROPYL)-3-ETHYLCARBODIIMIDE MOIETY. ELI LILLY AND COMPANY (US) 2000-10-03 US disclosed
EP-0994109-A2 1-(3-(1-Pyrrolidinyl)propyl)-3-ethylcarbodiimide and a solid phase coupling agent ELI LILLY AND COMPANY (US) 2000-04-19 EP disclosed
US-5998630-A A 1-(3-(1-PYRROLIDINYL)PROPY)-3-ETHYLCARBODIIMIDE ELI LILLY AND COMPANY (US) 1999-12-07 US disclosed
US-5942536-A USEFUL FOR TREATING MIGRAINE ELI LILLY AND COMPANY (US) 1999-08-24 US disclosed
WO-1997013512-A1 N-[2-SUBSTITUTED-3-(2-AMINOETHYL)-1H-INDOL-5-YL]-AMIDES: NEW 5-HT1F AGONISTS ELI LILLY AND COMPANY (US) 1997-04-17 WO disclosed
EP-0768301-A1 N-(2-substituted-3-(2-aminoethyl)-1H-indol-5-yl)-amides as new 5-HT1F agonists ELI LILLY AND COMPANY (US) 1997-04-16 EP disclosed